• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Atypical antipsychotics for mood and anxiety disorders: safe and effective adjuncts?

作者信息

Blier Pierre

出版信息

J Psychiatry Neurosci. 2005 Jul;30(4):232-3.

PMID:16049565
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1160557/
Abstract
摘要

相似文献

1
Atypical antipsychotics for mood and anxiety disorders: safe and effective adjuncts?用于治疗情绪和焦虑障碍的非典型抗精神病药物：安全有效的辅助药物？
J Psychiatry Neurosci. 2005 Jul;30(4):232-3.
2
Advances in treatment of mood and anxiety disorders: focus on atypical antipsychotics.情绪和焦虑症的治疗进展：聚焦非典型抗精神病药物
Bipolar Disord. 2003;5 Suppl 2:5-6. doi: 10.1111/j.1399-2406.2003.00064.x.
3
On the selection and use of atypical antipsychotics in the management of nonpsychotic mood and anxiety disorders.非典型抗精神病药物在非精神病性心境和焦虑障碍治疗中的选用
J Psychiatry Neurosci. 2005 Jul;30(4):304.
4
Atypical antipsychotics in primary generalized anxiety disorder or comorbid with mood disorders.非典型抗精神病药物用于原发性广泛性焦虑障碍或合并情绪障碍。
Expert Rev Neurother. 2009 Aug;9(8):1147-58. doi: 10.1586/ern.09.37.
5
Atypical antipsychotics and suicide in mood and anxiety disorders.非典型抗精神病药物与心境及焦虑障碍中的自杀行为
Bipolar Disord. 2003;5 Suppl 2:48-52. doi: 10.1111/j.1399-2406.2003.00062.x.
6
Tardive dyskinesia from atypical antipsychotic agents in patients with mood disorders in a clinical setting.在临床环境中，心境障碍患者使用非典型抗精神病药物引起的迟发性运动障碍。
J Affect Disord. 2013 Sep 25;150(3):868-71. doi: 10.1016/j.jad.2013.04.053. Epub 2013 May 30.
7
Treatment for mood and anxiety disorders: quetiapine and aripiprazole.心境和焦虑障碍的治疗：喹硫平和阿立哌唑。
Curr Psychiatry Rep. 2003 Aug;5(4):320-6. doi: 10.1007/s11920-003-0062-9.
8
Efficacy of atypical antipsychotics in mood disorders.非典型抗精神病药物在心境障碍中的疗效。
J Clin Psychopharmacol. 2003 Jun;23(3 Suppl 1):S9-14. doi: 10.1097/01.jcp.0000084036.22282.ea.
9
Mechanism of Action of Atypical Antipsychotic Drugs in Mood Disorders.心境障碍中新型抗精神病药物的作用机制。
Int J Mol Sci. 2020 Dec 15;21(24):9532. doi: 10.3390/ijms21249532.
10
'Sleep therapy' or medical malpractice?
S Afr Med J. 1997 Dec;87(12):1707.

引用本文的文献

1
Mechanism of Action of Atypical Antipsychotic Drugs in Mood Disorders.心境障碍中新型抗精神病药物的作用机制。
Int J Mol Sci. 2020 Dec 15;21(24):9532. doi: 10.3390/ijms21249532.
2
Buprenorphine/samidorphan combination for the adjunctive treatment of major depressive disorder: results of a phase III clinical trial (FORWARD-3).丁丙诺啡/沙美阿片受体激动剂联合用于重度抑郁症的辅助治疗：一项III期临床试验（FORWARD-3）的结果
Neuropsychiatr Dis Treat. 2019 Apr 4;15:795-808. doi: 10.2147/NDT.S199245. eCollection 2019.

本文引用的文献

1
Efficacy and tolerability of adjunctive ziprasidone in treatment-resistant depression: a randomized, open-label, pilot study.辅助使用齐拉西酮治疗难治性抑郁症的疗效和耐受性：一项随机、开放标签的试点研究。
J Clin Psychiatry. 2007 Jul;68(7):1071-7. doi: 10.4088/jcp.v68n0714.
2
Atypical antipsychotic augmentation of mood stabilizer therapy in bipolar disorder.双相情感障碍中使用非典型抗精神病药物增强心境稳定剂治疗
J Clin Psychiatry. 2005;66 Suppl 3:12-9.
3
Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study.低剂量利培酮增强氟伏沙明治疗强迫症：一项双盲、安慰剂对照研究。
Eur Neuropsychopharmacol. 2005 Jan;15(1):69-74. doi: 10.1016/j.euroneuro.2004.04.004.
4
A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obsessive-compulsive disorder refractory to serotonin reuptake inhibitors.一项针对对5-羟色胺再摄取抑制剂难治的强迫症患者加用喹硫平的双盲、随机、安慰剂对照试验。
J Clin Psychiatry. 2004 Aug;65(8):1040-8. doi: 10.4088/jcp.v65n0803.
5
Augmentation of serotonin reuptake inhibitors in refractory obsessive-compulsive disorder using adjunctive olanzapine: a placebo-controlled trial.使用辅助奥氮平增强5-羟色胺再摄取抑制剂治疗难治性强迫症：一项安慰剂对照试验。
J Clin Psychiatry. 2004 Apr;65(4):565-8. doi: 10.4088/jcp.v65n0418.
6
Development of an atherogenic metabolic risk factor profile associated with the use of atypical antipsychotics.与使用非典型抗精神病药物相关的动脉粥样硬化性代谢危险因素谱的发展。
J Clin Psychiatry. 2004 Apr;65(4):557-64. doi: 10.4088/jcp.v65n0417.
7
A double-blind, placebo-controlled trial of olanzapine addition in fluoxetine-refractory obsessive-compulsive disorder.奥氮平联合氟西汀治疗难治性强迫症的双盲、安慰剂对照试验。
Biol Psychiatry. 2004 Mar 1;55(5):553-5. doi: 10.1016/j.biopsych.2003.11.010.
8
Pharmacologic treatment of posttraumatic stress disorder: a focus on antipsychotic use.
Ann Clin Psychiatry. 2003 Sep-Dec;15(3-4):193-201. doi: 10.1023/b:acli.0000008173.01153.4e.
9
Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.奥氮平与奥氮平-氟西汀联合用药治疗双相I型抑郁症的疗效
Arch Gen Psychiatry. 2003 Nov;60(11):1079-88. doi: 10.1001/archpsyc.60.11.1079.
10
Risperidone augmentation in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study.
Int J Neuropsychopharmacol. 2003 Dec;6(4):397-401. doi: 10.1017/S1461145703003730.